Tectonic Therapeutic (TECX) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Sep 1, 2023Jun 1, 2023Dec 1, 2022

Total Assets

$168.7 M(-13.0%)$193.9 M(+1128.6%)$15.8 M-$47.2 M

Current Assets

$162.6 M(-13.2%)$187.4 M(+2461.7%)$7.3 M-$37.0 M

Non Current Assets

$6.1 M(-6.2%)$6.5 M(-23.0%)$8.5 M-$10.2 M

Total Liabilities

$18.4 M(-33.4%)$27.5 M(-71.2%)$95.6 M-$92.9 M

Current Liabilities

$17.3 M(-33.4%)$26.0 M(+117.5%)$12.0 M-$7.8 M

Long Term Liabilities

$1.0 M(-32.8%)$1.5 M(-98.2%)$83.6 M-$85.0 M

Shareholders Equity

$150.4 M(-9.6%)$166.4 M(+308.5%)-$79.8 M--$45.7 M

Book Value

$150.4 M(-9.6%)$166.4 M(+308.5%)-$79.8 M--$45.7 M

Working Capital

$145.3 M(-10.0%)$161.4 M(+3579.7%)-$4.6 M-$29.2 M

Cash And Cash Equivalents

$159.1 M(-14.1%)$185.1 M(+2824.6%)$6.3 M-$36.0 M

Accounts Payable

$2.6 M(-35.6%)$4.1 M(-10.9%)$4.6 M-$574.0 K

Accounts Receivable

-----

Short Term Debt

$1.9 M(+2.4%)$1.9 M(+6.5%)$1.8 M-$1.4 M

Long Term Debt

$1.0 M(-32.8%)$1.5 M(-48.3%)$3.0 M-$4.3 M

Total Debt

$3.0 M(-13.4%)$3.4 M(-27.8%)$4.8 M(+100.0%)$0.0(-100.0%)$5.8 M

Debt To Equity

0.0(0%)0.0(+133.3%)-0.1--0.1

Current Ratio

9.4(+30.2%)7.2(+1082.0%)0.6-4.7

Quick Ratio

-----

Inventory

-----

Retained Earnings

-$136.2 M(-14.9%)-$118.5 M(-43.2%)-$82.7 M--$47.8 M

PB Ratio

3.0(+108.9%)1.5---

Income statements

Sep 30, 2024Jun 30, 2024Sep 1, 2023Jun 1, 2023Dec 1, 2022

EPS

-$1.2(-39.5%)-$0.9(-26.0%)-$0.7(+3.8%)-$0.7(-1.6%)-$0.7

TTM EPS

-$2.1(-33.6%)-$1.5(+26.2%)-$2.1(-48.5%)-$1.4(-101.6%)-$0.7

Revenue

-----

TTM Revenue

-----

Total Expenses

$19.6 M(+71.9%)$11.4 M(+12.9%)$10.1 M(-4.9%)$10.6 M(+2.8%)$10.3 M

Operating Expenses

$19.6 M(+71.9%)$11.4 M(+12.9%)$10.1 M(-4.9%)$10.6 M(+2.8%)$10.3 M

Cost Of Goods Sold

-----

TTM Cost Of Goods Sold

-----

Gross Profit

-----

TTM Gross Profit

-----

Gross Margin

-----

Operating Profit

-$19.6 M(-71.9%)-$11.4 M(-12.9%)-$10.1 M(+4.9%)-$10.6 M(-2.8%)-$10.3 M

TTM Operating Profit

-$31.1 M(-44.2%)-$21.5 M(+30.7%)-$31.1 M(-48.2%)-$21.0 M(-102.8%)-$10.3 M

Operating Margin

-----

Net Income

-$17.7 M(-39.8%)-$12.7 M(-26.0%)-$10.1 M(+3.8%)-$10.5 M(-1.6%)-$10.3 M

TTM Net Income

-$30.4 M(-33.7%)-$22.7 M(+26.2%)-$30.8 M(-48.5%)-$20.7 M(-101.6%)-$10.3 M

Net Margin

-----

EBIT

-$17.7 M(-39.9%)-$12.6 M(-26.2%)-$10.0 M(+3.8%)-$10.4 M(-1.5%)-$10.3 M

TTM EBIT

-$30.3 M(-33.9%)-$22.7 M(+26.2%)-$30.7 M(-48.5%)-$20.7 M(-101.5%)-$10.3 M

EBITDA

-$17.7 M(-39.9%)-$12.6 M(-31.1%)-$9.6 M(+7.4%)-$10.4 M(-4.8%)-$9.9 M

TTM EBITDA

-$30.3 M(-36.1%)-$22.3 M(+25.7%)-$30.0 M(-47.4%)-$20.4 M(-104.8%)-$9.9 M

Selling, General & Administrative Expenses

$5.3 M(+22.4%)$4.3 M(+108.1%)$2.1 M(+12.0%)$1.9 M(-9.9%)$2.1 M

TTM SGA

$9.7 M(+50.2%)$6.4 M(+6.8%)$6.0 M(+53.1%)$3.9 M(+90.1%)$2.1 M

Depreciation And Amortization

$1.1 M(+59.5%)$713.0 K(-35.5%)$1.1 M(+50.5%)$734.0 K-

TTM D&A

$1.9 M(+1.8%)$1.8 M(-1.1%)$1.8 M(+150.5%)$734.0 K-

Interest Expense

$25.0 K(-10.7%)$28.0 K(-22.2%)$36.0 K(-10.0%)$40.0 K(+17.6%)$34.0 K

TTM Interest Expense

$53.0 K(-17.2%)$64.0 K(-41.8%)$110.0 K(+48.6%)$74.0 K(+117.7%)$34.0 K

Income Tax

-----

TTM Income Tax

-----

PE Ratio

-----

PS Ratio

-----

Cashflow statements

Sep 30, 2024Jun 30, 2024Sep 1, 2023Jun 1, 2023Dec 1, 2022

Cash From Operations

-$42.3 M(-86.5%)-$22.7 M(+21.9%)-$29.0 M(-41.3%)-$20.5 M-

TTM CFO

-$64.9 M(-25.6%)-$51.7 M(-4.3%)-$49.6 M(-141.3%)-$20.5 M-

Cash From Investing

-$153.0 K(-100.0%)$0.0(+100.0%)-$229.0 K(-3.1%)-$222.0 K-

TTM CFI

-$153.0 K(+33.2%)-$229.0 K(+49.2%)-$451.0 K(-103.2%)-$222.0 K-

Cash From Financing

$172.8 M(-3.5%)$179.1 M(+46854.6%)-$383.0 K(-42.4%)-$269.0 K-

TTM CFF

$351.9 M(+96.9%)$178.7 M(+27506.0%)-$652.0 K(-142.4%)-$269.0 K-

Free Cash Flow

-$42.4 M(-87.2%)-$22.7 M(+22.6%)-$29.3 M(-40.9%)-$20.8 M-

TTM FCF

-$65.1 M(-25.4%)-$51.9 M(-3.8%)-$50.0 M(-140.9%)-$20.8 M-

CAPEX

-----

TTM CAPEX

-----

Dividends Paid

-----

TTM Dividends Paid

-----

TTM Dividend Per Share

-----

TTM Dividend Yield

-----

Payout Ratio

-----